China represents an untapped market for GLP-1 class diabetes drugs, according to Novo Nordisk, which is predicting "good momentum" for its already-approved Victoza, and its successor semaglutide. With ...

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses on ...

Stay safe with updates on recalls, or tackle issues yourself with how-tos from our experts. Search for recalls by car Find out if there are recalls on a car you own or are interested in. Learn about ...

Jimmy Lai, the media mogul and China critic, was found guilty on two counts of conspiracy to collude with foreign forces under a Beijing-imposed national security law that could see him jailed for ...

For 33 years, we've provided live analysis and coverage of stocks in play, market-moving events, news headlines, corporate earnings, broker rating changes, and more.